Fast Company January 6, 2021
Ruth Reader

The ex-CEO of Haven—Amazon, Berkshire Hathaway, and JP Morgan’s just-ended health venture—on what he’s learned as a surgeon, researcher, and entrepreneur.

After three years, Haven, the much-anticipated health venture from Amazon, Berkshire Hathaway, and JP Morgan, is shutting down. Little information came from the company itself on the decision to end the business, merely stating that its founding companies would collaborate further in the future. When it disbands at the end of February, its staff will be divvied up among its three founding partners.

Haven was an attempt to exert some control over ever-rising healthcare costs while also ensuring quality. Dr. Atul Gawande, surgeon, researcher, and professor at Harvard Medical School, helmed the effort. Gawande was a surprising choice. As...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Healthcare System, Insurance, Interview / Q&A, Provider, Trends
New RNA-Based Sequencing Approach Tracks COVID Variants
CDC probe into fake Botox grows: 5 notes
More FTC Privacy Action
Over 70% of workers around the world are exposed to excessive heat each year, UN body finds
On Earth Day, Climate Change’s Impact On Infectious Diseases Looms

Share This Article